Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 100 entries
Sorted by: Best Match Show Resources per page
Guidelines for moduel development

field stations

Sprangers M.
GSID: CY_BRKFFWWUJ
M Sprangers, A Cull - Amsterdam, The Netherlands Cancer Institute, 1992

No abstract available.

Cite
Sprangers, M., & Cull, A. (1992). Guidelines for moduel development. Amsterdam, The Netherlands Cancer Institute.
Sprangers, M., and A. Cull. "Guidelines for moduel development." Amsterdam, The Netherlands Cancer Institute (1992).
Copy Download .nbib Format: MLA
Renal Thrombotic Microangiopathy Associated with the Use of Bortezomib in a Patient with Multiple Myeloma.

Case reports in hematology

Van Keer J, Delforge M, Dierickx D, Peerlinck K, Lerut E, Sprangers B.
PMID: 27293920
Case Rep Hematol. 2016;2016:6020691. doi: 10.1155/2016/6020691. Epub 2016 May 16.

Bortezomib is a first-generation proteasome inhibitor used in the treatment of multiple myeloma (MM). A few reports have linked bortezomib exposure with the development of thrombotic microangiopathy (TMA). We describe a case of biopsy-proven renal thrombotic microangiopathy associated with...

Cite
Van Keer J, Delforge M, Dierickx D, et al. Renal Thrombotic Microangiopathy Associated with the Use of Bortezomib in a Patient with Multiple Myeloma. Case Rep Hematol. 2016;2016:6020691doi: 10.1155/2016/6020691.
Van Keer, J., Delforge, M., Dierickx, D., Peerlinck, K., Lerut, E., & Sprangers, B. (2016). Renal Thrombotic Microangiopathy Associated with the Use of Bortezomib in a Patient with Multiple Myeloma. Case reports in hematology, 20166020691. https://doi.org/10.1155/2016/6020691
Van Keer, Jan, et al. "Renal Thrombotic Microangiopathy Associated with the Use of Bortezomib in a Patient with Multiple Myeloma." Case reports in hematology vol. 2016 (2016): 6020691. doi: https://doi.org/10.1155/2016/6020691
Van Keer J, Delforge M, Dierickx D, Peerlinck K, Lerut E, Sprangers B. Renal Thrombotic Microangiopathy Associated with the Use of Bortezomib in a Patient with Multiple Myeloma. Case Rep Hematol. 2016;2016:6020691. doi: 10.1155/2016/6020691. Epub 2016 May 16. PMID: 27293920; PMCID: PMC4884801.
Copy Download .nbib Format: NLM
Erratum to: Genetic variations underlying self-reported physical functioning: a review.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Thong MS, Sprangers MA, Sloan JA, Patrick DL, Yang P, van Noorden CJ.
PMID: 25480423
Qual Life Res. 2015 Jul;24(7):1797. doi: 10.1007/s11136-014-0883-5.

No abstract available.

Cite
Thong MS, Sprangers MA, Sloan JA, et al. Erratum to: Genetic variations underlying self-reported physical functioning: a review. Qual Life Res. 2015;24(7):1797doi: 10.1007/s11136-014-0883-5.
Thong, M. S., Sprangers, M. A., Sloan, J. A., Patrick, D. L., Yang, P., & van Noorden, C. J. (2015). Erratum to: Genetic variations underlying self-reported physical functioning: a review. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 24(7), 1797. https://doi.org/10.1007/s11136-014-0883-5
Thong, Melissa S Y, et al. "Erratum to: Genetic variations underlying self-reported physical functioning: a review." Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation vol. 24,7 (2015): 1797. doi: https://doi.org/10.1007/s11136-014-0883-5
Thong MS, Sprangers MA, Sloan JA, Patrick DL, Yang P, van Noorden CJ. Erratum to: Genetic variations underlying self-reported physical functioning: a review. Qual Life Res. 2015 Jul;24(7):1797. doi: 10.1007/s11136-014-0883-5. PMID: 25480423.
Copy Download .nbib Format: NLM
Structural equation modeling-based effect-size indices were used to evaluate and interpret the impact of response shift effects.

Journal of clinical epidemiology

Verdam MGE, Oort FJ, Sprangers MAG.
PMID: 28342903
J Clin Epidemiol. 2017 May;85:37-44. doi: 10.1016/j.jclinepi.2017.02.012. Epub 2017 Mar 22.

OBJECTIVES: The investigation of response shift in patient-reported outcomes (PROs) is important in both clinical practice and research. Insight into the presence and strength of response shift effects is necessary for a valid interpretation of change.STUDY DESIGN AND SETTING:...

Cite
Verdam MGE, Oort FJ, Sprangers MAG. Structural equation modeling-based effect-size indices were used to evaluate and interpret the impact of response shift effects. J Clin Epidemiol. 2017;85:37-44doi: 10.1016/j.jclinepi.2017.02.012.
Verdam, M. G. E., Oort, F. J., & Sprangers, M. A. G. (2017). Structural equation modeling-based effect-size indices were used to evaluate and interpret the impact of response shift effects. Journal of clinical epidemiology, 8537-44. https://doi.org/10.1016/j.jclinepi.2017.02.012
Verdam, Mathilde G E, et al. "Structural equation modeling-based effect-size indices were used to evaluate and interpret the impact of response shift effects." Journal of clinical epidemiology vol. 85 (2017): 37-44. doi: https://doi.org/10.1016/j.jclinepi.2017.02.012
Verdam MGE, Oort FJ, Sprangers MAG. Structural equation modeling-based effect-size indices were used to evaluate and interpret the impact of response shift effects. J Clin Epidemiol. 2017 May;85:37-44. doi: 10.1016/j.jclinepi.2017.02.012. Epub 2017 Mar 22. PMID: 28342903.
Copy Download .nbib Format: NLM
Fatigue is Highly Prevalent in Patients with Asthma and Contributes to the Burden of Disease.

Journal of clinical medicine

Van Herck M, Spruit MA, Burtin C, Djamin R, Antons J, Goërtz YMJ, Ebadi Z, Janssen DJA, Vercoulen JH, Peters JB, Thong MSY, Otker J, Coors A, Sprangers MAG, Muris JWM, Wouters EFM, van 't Hul AJ.
PMID: 30477110
J Clin Med. 2018 Nov 23;7(12). doi: 10.3390/jcm7120471.

The 2018 update of the Global Strategy for Asthma Management and Prevention does not mention fatigue-related symptoms. Nevertheless, patients with asthma frequently report tiredness, lack of energy, and daytime sleepiness. Quantitative research regarding the prevalence of fatigue in asthmatic...

Cite
Van Herck M, Spruit MA, Burtin C, et al. Fatigue is Highly Prevalent in Patients with Asthma and Contributes to the Burden of Disease. J Clin Med. 2018;7(12)doi: 10.3390/jcm7120471.
Van Herck, M., Spruit, M. A., Burtin, C., Djamin, R., Antons, J., Goërtz, Y. M. J., Ebadi, Z., Janssen, D. J. A., Vercoulen, J. H., Peters, J. B., Thong, M. S. Y., Otker, J., Coors, A., Sprangers, M. A. G., Muris, J. W. M., Wouters, E. F. M., & van 't Hul, A. J. (2018). Fatigue is Highly Prevalent in Patients with Asthma and Contributes to the Burden of Disease. Journal of clinical medicine, 7(12), . https://doi.org/10.3390/jcm7120471
Van Herck, Maarten, et al. "Fatigue is Highly Prevalent in Patients with Asthma and Contributes to the Burden of Disease." Journal of clinical medicine vol. 7,12 (2018). doi: https://doi.org/10.3390/jcm7120471
Van Herck M, Spruit MA, Burtin C, Djamin R, Antons J, Goërtz YMJ, Ebadi Z, Janssen DJA, Vercoulen JH, Peters JB, Thong MSY, Otker J, Coors A, Sprangers MAG, Muris JWM, Wouters EFM, van 't Hul AJ. Fatigue is Highly Prevalent in Patients with Asthma and Contributes to the Burden of Disease. J Clin Med. 2018 Nov 23;7(12). doi: 10.3390/jcm7120471. PMID: 30477110; PMCID: PMC6306949.
Copy Download .nbib Format: NLM
Self-Maintaining Gut Macrophages Are Essential for Intestinal Homeostasis.

Cell

De Schepper S, Verheijden S, Aguilera-Lizarraga J, Viola MF, Boesmans W, Stakenborg N, Voytyuk I, Schmidt I, Boeckx B, Dierckx de Casterlé I, Baekelandt V, Gonzalez Dominguez E, Mack M, Depoortere I, De Strooper B, Sprangers B, Himmelreich U, Soenen S, Guilliams M, Vanden Berghe P, Jones E, Lambrechts D, Boeckxstaens G.
PMID: 30682373
Cell. 2019 Jan 24;176(3):676. doi: 10.1016/j.cell.2019.01.010.

No abstract available.

Cite
De Schepper S, Verheijden S, Aguilera-Lizarraga J, et al. Self-Maintaining Gut Macrophages Are Essential for Intestinal Homeostasis. Cell. 2019;176(3):676doi: 10.1016/j.cell.2019.01.010.
De Schepper, S., Verheijden, S., Aguilera-Lizarraga, J., Viola, M. F., Boesmans, W., Stakenborg, N., Voytyuk, I., Schmidt, I., Boeckx, B., Dierckx de Casterlé, I., Baekelandt, V., Gonzalez Dominguez, E., Mack, M., Depoortere, I., De Strooper, B., Sprangers, B., Himmelreich, U., Soenen, S., Guilliams, M., Vanden Berghe, P., Jones, E., Lambrechts, D., & Boeckxstaens, G. (2019). Self-Maintaining Gut Macrophages Are Essential for Intestinal Homeostasis. Cell, 176(3), 676. https://doi.org/10.1016/j.cell.2019.01.010
De Schepper, Sebastiaan, et al. "Self-Maintaining Gut Macrophages Are Essential for Intestinal Homeostasis." Cell vol. 176,3 (2019): 676. doi: https://doi.org/10.1016/j.cell.2019.01.010
De Schepper S, Verheijden S, Aguilera-Lizarraga J, Viola MF, Boesmans W, Stakenborg N, Voytyuk I, Schmidt I, Boeckx B, Dierckx de Casterlé I, Baekelandt V, Gonzalez Dominguez E, Mack M, Depoortere I, De Strooper B, Sprangers B, Himmelreich U, Soenen S, Guilliams M, Vanden Berghe P, Jones E, Lambrechts D, Boeckxstaens G. Self-Maintaining Gut Macrophages Are Essential for Intestinal Homeostasis. Cell. 2019 Jan 24;176(3):676. doi: 10.1016/j.cell.2019.01.010. PMID: 30682373.
Copy Download .nbib Format: NLM
Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283-288.

Annals of oncology : official journal of the European Society for Medical Oncology

Bjelic-Radisic V, Cardoso F, Cameron D, Brain E, Kuljanic K, da Costa RA, Conroy T, Inwald EC, Serpentini S, Pinto M, Weis J, Morag O, Lindviksmoen Astrup G, Tomaszewski KA, Pogoda K, Sinai P, Sprangers M, Aaronson N, Velikova G, Greimel E, Arraras J, Bottomley A.
PMID: 32089397
Ann Oncol. 2020 Apr;31(4):552. doi: 10.1016/j.annonc.2020.02.001. Epub 2020 Feb 20.

No abstract available.

Cite
Bjelic-Radisic V, Cardoso F, Cameron D, et al. Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283-288. Ann Oncol. 2020;31(4):552doi: 10.1016/j.annonc.2020.02.001.
Bjelic-Radisic, V., Cardoso, F., Cameron, D., Brain, E., Kuljanic, K., da Costa, R. A., Conroy, T., Inwald, E. C., Serpentini, S., Pinto, M., Weis, J., Morag, O., Lindviksmoen Astrup, G., Tomaszewski, K. A., Pogoda, K., Sinai, P., Sprangers, M., Aaronson, N., Velikova, G., Greimel, E., Arraras, J., Bottomley, A. (2020). Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283-288. Annals of oncology : official journal of the European Society for Medical Oncology, 31(4), 552. https://doi.org/10.1016/j.annonc.2020.02.001
Bjelic-Radisic, V, et al. "Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283-288." Annals of oncology : official journal of the European Society for Medical Oncology vol. 31,4 (2020): 552. doi: https://doi.org/10.1016/j.annonc.2020.02.001
Bjelic-Radisic V, Cardoso F, Cameron D, Brain E, Kuljanic K, da Costa RA, Conroy T, Inwald EC, Serpentini S, Pinto M, Weis J, Morag O, Lindviksmoen Astrup G, Tomaszewski KA, Pogoda K, Sinai P, Sprangers M, Aaronson N, Velikova G, Greimel E, Arraras J, Bottomley A. Corrigendum to An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45: Ann Oncol 2020; Volume 31, Issue 2, Pages 283-288. Ann Oncol. 2020 Apr;31(4):552. doi: 10.1016/j.annonc.2020.02.001. Epub 2020 Feb 20. PMID: 32089397.
Copy Download .nbib Format: NLM
Pembrolizumab-related renal toxicities: diagnosis first, treatment later.

Clinical kidney journal

Sprangers B.
PMID: 30746131
Clin Kidney J. 2019 Feb;12(1):78-80. doi: 10.1093/ckj/sfy114. Epub 2018 Dec 01.

Checkpoint inhibitors are increasingly used to treat different types of malignancy and have been associated with renal toxicities. In this issue, Izzedine

Cite
Sprangers B. Pembrolizumab-related renal toxicities: diagnosis first, treatment later. Clin Kidney J. 2018;12(1):78-80doi: 10.1093/ckj/sfy114.
Sprangers, B. (2019). Pembrolizumab-related renal toxicities: diagnosis first, treatment later. Clinical kidney journal, 12(1), 78-80. https://doi.org/10.1093/ckj/sfy114
Sprangers, Ben. "Pembrolizumab-related renal toxicities: diagnosis first, treatment later." Clinical kidney journal vol. 12,1 (2019): 78-80. doi: https://doi.org/10.1093/ckj/sfy114
Sprangers B. Pembrolizumab-related renal toxicities: diagnosis first, treatment later. Clin Kidney J. 2019 Feb;12(1):78-80. doi: 10.1093/ckj/sfy114. Epub 2018 Dec 01. PMID: 30746131; PMCID: PMC6366137.
Copy Download .nbib Format: NLM
Patterns of renal osteodystrophy 1 year after kidney transplantation.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Jørgensen HS, Behets G, Bammens B, Claes K, Meijers B, Naesens M, Sprangers B, Kuypers DRJ, D'Haese P, Evenepoel P.
PMID: 34383929
Nephrol Dial Transplant. 2021 Nov 09;36(11):2130-2139. doi: 10.1093/ndt/gfab239.

BACKGROUND: Renal osteodystrophy is considered common, but is not well characterized in contemporary kidney transplant recipients. This study reports extensively on bone phenotype by bone histomorphometry, bone densitometry and novel bone biomarkers 1 year after kidney transplantation.METHODS: A transiliac...

Cite
Jørgensen HS, Behets G, Bammens B, et al. Patterns of renal osteodystrophy 1 year after kidney transplantation. Nephrol Dial Transplant. 2021;36(11):2130-2139doi: 10.1093/ndt/gfab239.
Jørgensen, H. S., Behets, G., Bammens, B., Claes, K., Meijers, B., Naesens, M., Sprangers, B., Kuypers, D. R. J., D'Haese, P., & Evenepoel, P. (2021). Patterns of renal osteodystrophy 1 year after kidney transplantation. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 36(11), 2130-2139. https://doi.org/10.1093/ndt/gfab239
Jørgensen, Hanne Skou, et al. "Patterns of renal osteodystrophy 1 year after kidney transplantation." Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association vol. 36,11 (2021): 2130-2139. doi: https://doi.org/10.1093/ndt/gfab239
Jørgensen HS, Behets G, Bammens B, Claes K, Meijers B, Naesens M, Sprangers B, Kuypers DRJ, D'Haese P, Evenepoel P. Patterns of renal osteodystrophy 1 year after kidney transplantation. Nephrol Dial Transplant. 2021 Nov 09;36(11):2130-2139. doi: 10.1093/ndt/gfab239. PMID: 34383929.
Copy Download .nbib Format: NLM
Response shift in results of patient-reported outcome measures: a commentary to The Response Shift-in Sync Working Group initiative.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Sprangers MAG, Sajobi T, Vanier A, Mayo NE, Sawatzky R, Lix LM, Oort FJ, Sébille V.
PMID: 33481193
Qual Life Res. 2021 Dec;30(12):3299-3308. doi: 10.1007/s11136-020-02747-4. Epub 2021 Jan 22.

PURPOSE: The Working Group undertook a critical, comprehensive synthesis of the response shift work to date. We aimed to (1) describe the rationale for this initiative; (2) outline how the Working Group operated; (3) summarize the papers that comprise...

Cite
Sprangers MAG, Sajobi T, Vanier A, et al. Response shift in results of patient-reported outcome measures: a commentary to The Response Shift-in Sync Working Group initiative. Qual Life Res. 2021;30(12):3299-3308doi: 10.1007/s11136-020-02747-4.
Sprangers, M. A. G., Sajobi, T., Vanier, A., Mayo, N. E., Sawatzky, R., Lix, L. M., Oort, F. J., Sébille, V. (2021). Response shift in results of patient-reported outcome measures: a commentary to The Response Shift-in Sync Working Group initiative. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 30(12), 3299-3308. https://doi.org/10.1007/s11136-020-02747-4
Sprangers, Mirjam A G, et al. "Response shift in results of patient-reported outcome measures: a commentary to The Response Shift-in Sync Working Group initiative." Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation vol. 30,12 (2021): 3299-3308. doi: https://doi.org/10.1007/s11136-020-02747-4
Sprangers MAG, Sajobi T, Vanier A, Mayo NE, Sawatzky R, Lix LM, Oort FJ, Sébille V. Response shift in results of patient-reported outcome measures: a commentary to The Response Shift-in Sync Working Group initiative. Qual Life Res. 2021 Dec;30(12):3299-3308. doi: 10.1007/s11136-020-02747-4. Epub 2021 Jan 22. PMID: 33481193; PMCID: PMC8602228.
Copy Download .nbib Format: NLM
Fatigue in patients with chronic disease: results from the population-based Lifelines Cohort Study.

Scientific reports

Goërtz YMJ, Braamse AMJ, Spruit MA, Janssen DJA, Ebadi Z, Van Herck M, Burtin C, Peters JB, Sprangers MAG, Lamers F, Twisk JWR, Thong MSY, Vercoulen JH, Geerlings SE, Vaes AW, Beijers RJHCG, van Beers M, Schols AMWJ, Rosmalen JGM, Knoop H.
PMID: 34697347
Sci Rep. 2021 Oct 25;11(1):20977. doi: 10.1038/s41598-021-00337-z.

(1) To evaluate the prevalence of severe and chronic fatigue in subjects with and without chronic disease; (2) to assess to which extent multi-morbidity contributes to severe and chronic fatigue; and (3) to identify predisposing and associated factors for...

Cite
Goërtz YMJ, Braamse AMJ, Spruit MA, et al. Fatigue in patients with chronic disease: results from the population-based Lifelines Cohort Study. Sci Rep. 2021;11(1):20977doi: 10.1038/s41598-021-00337-z.
Goërtz, Y. M. J., Braamse, A. M. J., Spruit, M. A., Janssen, D. J. A., Ebadi, Z., Van Herck, M., Burtin, C., Peters, J. B., Sprangers, M. A. G., Lamers, F., Twisk, J. W. R., Thong, M. S. Y., Vercoulen, J. H., Geerlings, S. E., Vaes, A. W., Beijers, R. J. H. C. G., van Beers, M., Schols, A. M. W. J., Rosmalen, J. G. M., & Knoop, H. (2021). Fatigue in patients with chronic disease: results from the population-based Lifelines Cohort Study. Scientific reports, 11(1), 20977. https://doi.org/10.1038/s41598-021-00337-z
Goërtz, Yvonne M J, et al. "Fatigue in patients with chronic disease: results from the population-based Lifelines Cohort Study." Scientific reports vol. 11,1 (2021): 20977. doi: https://doi.org/10.1038/s41598-021-00337-z
Goërtz YMJ, Braamse AMJ, Spruit MA, Janssen DJA, Ebadi Z, Van Herck M, Burtin C, Peters JB, Sprangers MAG, Lamers F, Twisk JWR, Thong MSY, Vercoulen JH, Geerlings SE, Vaes AW, Beijers RJHCG, van Beers M, Schols AMWJ, Rosmalen JGM, Knoop H. Fatigue in patients with chronic disease: results from the population-based Lifelines Cohort Study. Sci Rep. 2021 Oct 25;11(1):20977. doi: 10.1038/s41598-021-00337-z. PMID: 34697347; PMCID: PMC8546086.
Copy Download .nbib Format: NLM
Diagnostic Accuracy of Noninvasive Bone Turnover Markers in Renal Osteodystrophy.

American journal of kidney diseases : the official journal of the National Kidney Foundation

Jørgensen HS, Behets G, Viaene L, Bammens B, Claes K, Meijers B, Naesens M, Sprangers B, Kuypers D, Cavalier E, D'Haese P, Evenepoel P.
PMID: 34710517
Am J Kidney Dis. 2021 Oct 25; doi: 10.1053/j.ajkd.2021.07.027. Epub 2021 Oct 25.

RATIONALE & OBJECTIVE: Bone biopsy remains the gold standard for diagnosing renal osteodystrophy as comparable non-invasive alternatives have yet to be established. The aim of this study was to investigate the diagnostic accuracy of biochemical markers of skeletal remodeling...

Cite
Jørgensen HS, Behets G, Viaene L, et al. Diagnostic Accuracy of Noninvasive Bone Turnover Markers in Renal Osteodystrophy. Am J Kidney Dis. 2021;doi: 10.1053/j.ajkd.2021.07.027.
Jørgensen, H. S., Behets, G., Viaene, L., Bammens, B., Claes, K., Meijers, B., Naesens, M., Sprangers, B., Kuypers, D., Cavalier, E., D'Haese, P., & Evenepoel, P. (2021). Diagnostic Accuracy of Noninvasive Bone Turnover Markers in Renal Osteodystrophy. American journal of kidney diseases : the official journal of the National Kidney Foundation, . https://doi.org/10.1053/j.ajkd.2021.07.027
Jørgensen, Hanne Skou, et al. "Diagnostic Accuracy of Noninvasive Bone Turnover Markers in Renal Osteodystrophy." American journal of kidney diseases : the official journal of the National Kidney Foundation vol. (2021). doi: https://doi.org/10.1053/j.ajkd.2021.07.027
Jørgensen HS, Behets G, Viaene L, Bammens B, Claes K, Meijers B, Naesens M, Sprangers B, Kuypers D, Cavalier E, D'Haese P, Evenepoel P. Diagnostic Accuracy of Noninvasive Bone Turnover Markers in Renal Osteodystrophy. Am J Kidney Dis. 2021 Oct 25; doi: 10.1053/j.ajkd.2021.07.027. Epub 2021 Oct 25. PMID: 34710517.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 100 entries